Timisoara Medical Journal

(ISSN: 1583-526X) Open Access Journal
Rss Feed:
Timisoara Med 2021, 2021(2), 2; doi: 10.35995/tmj20210202

Dual Cancer in a Patient with Type 1 Gaucher Disease: Case Report and Literature Review

1 Department of Gastroenterology and Hepatology, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania; (A.P.); (R.S.)
2 Department of Anatomy and Embryology, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania;
* Correspondence: ; Tel.: +40-742892603
* Author to whom correspondence should be addressed.
Received: 18 May 2021 / Revised: 10 Oct 2021 / Accepted: 10 Oct 2021 / Published: 26 Oct 2021
View Full-text Download PDF (1558kb)

Abstract

Gaucher Disease (GD) is a rare inherited lysosomal storage disease caused by biallelic mutations in the gene encoding the lysosomal enzyme acid β-glucocerebrosidase, with progressive accumulation of the sphingolipid glucosylceramide in the lysosomes of macrophages, mainly in the liver, spleen, bone, and bone marrow. It is characterized by anemia, thrombocytopenia, hepatosplenomegaly, sometimes severe bone involvement and, in certain forms, neurological involvement. We present the case of a 77-year-old male, diagnosed in 2006, at 63, with GD type1. At the onset, the patient presented fatigue, asthenia, upper abdominal discomfort, skin pallor and minor bone pain. During follow-up, CT was performed and displayed an enlarged spleen (25 cm) and a well-defined mass in the kidney cortex, but it could not establish whether it was malignant or not. Considering the patient refused surgery at that moment, a new CT exam was performed six months later, and the kidney tumor significantly increased in size. Nephrectomy and necessity splenectomy were performed, and recovery was uneventful. The histopathological examination revealed clear cell renal cell carcinoma, grade 2 Fuhrman. Enzyme substitution therapy with Imiglucerasum was initiated in 2012 with favorable evolution. Seven years later, during a routine ultrasound follow-up, a 4/3.8 cm hyperechoic mass was found in the eighth liver segment. The biological tests revealed a high value of alpha-fetoprotein (AFP-185.2 ng/mL). Considering the patient’s history, possible diagnoses of the newly found focal liver lesion were: gaucheroma, metastasis secondary to kidney cancer, or a primitive liver tumor. Core biopsy was performed, and it was suggestive of a poorly differentiated hepatocellular carcinoma G3. A non-anatomical resection of liver segments VII and VIII with partial resection of inferior vena cava was performed, followed by full post-operative recovery. A histopathological examination confirmed the initial diagnosis. Currently, one month postoperatively, the patient in good clinical condition, continues the enzyme replacement treatment and is undergoing oncological follow-up. We presented a complex case of GD, diagnosed at an advanced age, who responded well to substitution therapy in regard to hematologic and bone symptoms, but who unfortunately developed two types of cancer managed aggressively despite the advanced age.
Keywords: Gaucher Disease; hepatocarcinoma; renal carcinoma; malignancy
OPEN ACCESS
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
CITE
Popa, A.; Lupulescu, P.; Iacob, N.; Sirli, R. Dual Cancer in a Patient with Type 1 Gaucher Disease: Case Report and Literature Review. Timisoara_Med 2021, 2021, 2.
Popa A, Lupulescu P, Iacob N, Sirli R. Dual Cancer in a Patient with Type 1 Gaucher Disease: Case Report and Literature Review. Timisoara Medical Journal. 2021; 2021(2):2.
Popa, Alexandru; Lupulescu, Patricia; Iacob, Nicoleta; Sirli, Roxana. 2021. "Dual Cancer in a Patient with Type 1 Gaucher Disease: Case Report and Literature Review." Timisoara_Med 2021, no. 2: 2.
Not implemented
SHARE